🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12164+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12164 recruiting trials

Phase 3RecruitingNCT06350032

Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

🏥 AOP Orphan Pharmaceuticals AG📍 5 sites📅 Started Jul 2024View details ↗
RecruitingNCT06377579

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

👨‍⚕️ Pierre PETERLIN, Dr, French Innovative Leukemia Organisation📍 21 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06219863

Harness-based Mobility Intervention for Infants With Down Syndrome

👨‍⚕️ Jana Iverson, PhD, Boston University📍 1 site📅 Started Jul 2024View details ↗
Phase 1, PHASE2RecruitingNCT06434363

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

👨‍⚕️ Chitra Hosing, MD, MDAnderson Cancer Center📍 2 sites📅 Started Jul 2024View details ↗
RecruitingNCT07414511

Hemophilia A Research Program

👨‍⚕️ Jill M Johnsen, MD, University of Washington📍 1 site📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT05373264

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

👨‍⚕️ Prof. dr. R.T. Gansevoort, University Medical Center Groningen📍 12 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT05927428

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

🏥 BRIM Biotechnology Inc.📍 1 site📅 Started Jul 2024View details ↗
Phase 3Enrolling by InvitationNCT06415344

Long-term Extension of GTX-102 in Angelman Syndrome

👨‍⚕️ Medical Director, Ultragenyx Pharmaceuticals Inc.📍 23 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06519760

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

👨‍⚕️ Kan Gong, Peking University First Hospital📍 1 site📅 Started Jul 2024View details ↗
NAEnrolling by InvitationNCT05737602

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

👨‍⚕️ Giselle Perez, PhD, Massachusetts General Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 2, PHASE3RecruitingNCT06470191

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 21 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06512779

Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals

👨‍⚕️ Ching-Hsia Hung, PhD, National Cheng Kung University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06513429

IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)

🏥 Peking University Third Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 3Enrolling by InvitationNCT06475742

Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

👨‍⚕️ Clinical Trials, Viatris Innovation GmbH📍 92 sites📅 Started Jul 2024View details ↗
Phase 4RecruitingNCT05841758

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis

🏥 Hospices Civils de Lyon📍 21 sites📅 Started Jul 2024View details ↗
RecruitingNCT07570459

TREMOR IN CHARCOT-MARIE-TOOTH

🏥 University Medical Center Goettingen📍 1 site📅 Started Jul 2024View details ↗
Enrolling by InvitationNCT06629623

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

👨‍⚕️ Hongling Chu, PhD, Peking University Third Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06476184

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

👨‍⚕️ Benoit YOU, HCL - Centre Hospitalier Lyon Sud📍 72 sites📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT06251310

SW-682 in Advanced Solid Tumors

🏥 SpringWorks Therapeutics, Inc.📍 8 sites📅 Started Jul 2024View details ↗
RecruitingNCT07570446

AUTONOMOUS DISORDERS IN CMT

🏥 University Medical Center Goettingen📍 1 site📅 Started Jul 2024View details ↗
← PreviousPage 263 of 609Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →